Labrada ElastiJoint
Labrada ElastiJoint, licence 80042829: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Empire Health Distribution Inc.
- NPN or DIN-HM
- 80042829
- Status
- Active licence
- Licence date
- 14 June 2013
- Revision date
- Not provided
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide L-ascorbique Source : Vitamine C | 990.0 mg | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 2000.0 mg | Not calculated |
| Collagène hydrolysé Source : Collagène hydrolysé | 5000.0 mg | Not calculated |
Non-medicinal ingredients
Saveur de raisin, Bleu FD&C n° 1, Acésulfame potassium, Saveur de punch aux fruits, Rouge FD&C N° 40, NA, Sucralose, Betterave rouge, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the support joint health. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Helps in connective tissue formation and in the development and maintenance of bones and cartilage.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use as a source of protein.
Source
Official Health Canada record, licence 80042829
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.